Antti Cajanus

发表

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis

R. Vanninen, A. Hall, P. Hartikainen, 2020, Annals of clinical and translational neurology.

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders

P. Hartikainen, S. Helisalmi, S. Herukka, 2019, Journal of Neurology.

Grey matter atrophy in patients with benign multiple sclerosis

J. Lötjönen, P. Hartikainen, J. Koikkalainen, 2022, Brain and behavior.

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis

D. Rueckert, H. Soininen, R. Vanninen, 2018, Dementia and Geriatric Cognitive Disorders Extra.

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia

R. Vanninen, P. Hartikainen, S. Heikkinen, 2022, Journal of Neurology.

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS

M. Hiltunen, N. Huber, A. Remes, 2019, Front. Neurosci..

Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers

A. Remes, A. Haapasalo, Antti Cajanus, 2019, Front. Neurosci..

Comparison of Prodromal Symptoms of Patients with Behavioral Variant Frontotemporal Dementia and Alzheimer Disease

P. Hartikainen, A. Koivisto, A. Remes, 2020, Dementia and Geriatric Cognitive Disorders.

GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

P. Hartikainen, S. Helisalmi, A. Koivisto, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia

H. Soininen, R. Vanninen, A. Hall, 2019, Front. Neurol..